IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Astonea Labs IPO is a book build IPO listing on BSE SME exchange. The company is based in Chandigarh and caters to Pharmaceutical sector. Oneview Corporate Advisors Private is the merchant banker of Astonea Labs IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 27th August 2024.
Astonea Labs IPO posted revenues of Rs 80.19 crores and PAT of Rs 3.81 crores in FY25 on annualised basis.Financial results of Astonea Labs IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Astonea Labs IPO PAT Margin is 4.74%, ROCE (Return on Capital Employed) is 22.95% as per latest financial. The below table shows Astonea Labs IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Astonea Labs IPO is Rs [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Astonea Labs IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Astonea Labs IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Astonea Labs IPO is ₹[●] Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Astonea Labs IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Astonea Labs IPO reported revenue of ₹80.19 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Astonea Labs IPO provide insights into sales growth, market demand, and business scalability.
Astonea Labs recorded an EBITDA of ₹ 11.71 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Astonea Labs Profit After Tax (PAT) is ₹3.80 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 80.19 Cr.
EBITDA Margin:
14.60
%
Net Worth: ₹ 11.96 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 3.59 times
Astonea Labs operates in Pharmaceutical and . The Issue is listed on BSE SME in Apr, 2025. Astonea Labs IPO size was with Issue price of .
Merchant Banker(s) of Astonea Labs IPO: Oneview Corporate Advisors Private Limited
Astonea Labs IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Astonea Labs IPO listed at a listing price of against the offer price of .
The current market price of Astonea Labs is .
Why Us?
